Cargando…
Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
In 2008, a national human papillomavirus (HPV) immunization program using a bivalent vaccine against HPV types 16 and 18 was implemented in Scotland along with a national surveillance program designed to determine the longitudinal effects of vaccination on HPV infection at the population level. Each...
Autores principales: | Cameron, Ross L., Kavanagh, Kimberley, Pan, Jiafeng, Love, John, Cuschieri, Kate, Robertson, Chris, Ahmed, Syed, Palmer, Timothy, Pollock, Kevin G.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696690/ https://www.ncbi.nlm.nih.gov/pubmed/26692336 http://dx.doi.org/10.3201/eid2201.150736 |
Ejemplares similares
-
Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
por: Kavanagh, Kimberley, et al.
Publicado: (2013) -
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
por: Palmer, Tim, et al.
Publicado: (2019) -
Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
por: Pollock, K G J, et al.
Publicado: (2014) -
Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings
por: Conway, David I., et al.
Publicado: (2016) -
Risk-factors for methadone-specific deaths in Scotland’s methadone-prescription clients between 2009 and 2013*
por: Gao, Lu, et al.
Publicado: (2016)